期刊文献+

毛果芸香碱和布林佐胺滴眼液对兔眼表组织的影响 被引量:11

Effects of pilocarpine and brinzolamide on rabbit ocular surface
暂未订购
导出
摘要 目的:探讨抗青光眼药物毛果芸香碱和布林佐胺滴眼液及各自的防腐剂三氯叔丁醇和氯化苯甲烃胺(BAC)对兔眼表组织的影响。方法:选取新西兰大白兔15只,分为正常对照组(3只)、毛果芸香碱组(A组,6只)和布林佐胺组(B组,6只)。用药组右眼使用青光眼药物毛果芸香碱或布林佐胺滴眼液,左眼使用对应的防腐剂三氯叔丁醇或BAC,连续用药30d。取球结膜组织行苏木素-伊红(HE)染色计数结膜上皮层炎症细胞数;角膜行扫描电镜检测并进行上皮损害分级评分。结果:与正常对照组比较,布林佐胺滴眼液(P<0.01)和防腐剂BAC(P<0.01)导致球结膜上皮层炎症细胞浸润增多;毛果芸香碱滴眼液(P>0.05)和三氯叔丁醇(P>0.05)引起的球结膜炎症细胞增多不明显。布林佐胺滴眼液导致球结膜炎症细胞增加的程度较毛果芸香碱滴眼液严重(P<0.01)。青光眼药物和防腐剂均可导致兔角膜上皮超微结构的损伤,表现为角膜上皮细胞六边形结构变为不规则、边界不清、细胞膜皱缩、细胞间距增宽、上皮细胞表面的微绒毛丢失、细胞空洞和暗细胞增加。布林佐胺滴眼液和BAC引起的角膜损害较毛果芸香碱滴眼液(P<0.01)和三氯叔丁醇明显(P<0.05)。各组左右两眼的球结膜炎症细胞数和角膜损害评分均无显著差异。结论:布林佐胺滴眼液和防腐剂BAC使用1个月后可导致兔球结膜炎症细胞增加和角膜上皮细胞损伤,毛果芸香碱滴眼液和三氯叔丁醇主要引起角膜上皮超微结构的变化;防腐剂是引起眼表损伤的主要原因。布林佐胺滴眼液对兔眼表的损伤较毛果芸香碱滴眼液严重。 AIM : To evaluate the effects of pilocarpine, brinzolamide and the preservatives of them on corneal epithelial cells and the histopathology of rabbit conjunctiva. METHODS : Fifteen New Zealand white rabbits weighing 1.5 kg to 2. 5 kg were randomly divided into three groups. One group with three rabbits served as untreated controls. Pilocarpine 1% and brinzolamide 1% each were administered to the right eyes in one treated group, and the preservatives ( chlorobutanol 0. 01% in pilocarpine, benzalkonium chloride 0. 01% in brinzolamide) to the left eyes. Corneal epithelial damage was evaluated by scanning electron microscopy, and conjunctival specimens were examined under light microscopy. RESULTS: Compared with normal controls, brinzolamide and BAC caused corneal epithelium damage and increased number of inflammatory cells in the conjunctiva, while pilocarpine and the preservative chlorobutanol mainly influenced the corneal epithelium. Brinzolamide produced significantly more damage than pilocarpine ( P 〈 0. 01 ) in corneal epithelium. In the conjunctival tissue, the number of inflammatory cells in the epithelium was significantly higher in eyes treated with brinzolamide than that with pilocarpine (P 〈0. 01 ). CONCLUSION: When applied to rabbit eyes, brinzolamide, pilocarpine and the preservatives result in corneal damage and eonjunctival inflammatory cell infiltration. The preservatives play a major role in the ocular surface adverse effects. Brinzolamide appears to have more influences on ocular surface compared with piloeapine.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第11期2251-2256,共6页 Chinese Journal of Pathophysiology
基金 广东省科技基础条件建设资助项目(No.2007A060305009) 广东省科技计划资助项目(No.2003C32725)
关键词 青光眼 毛果芸香碱 布林佐胺 Glaucoma Pilocarpine Brinzolamide
  • 相关文献

参考文献13

  • 1Baudouin C, Garcher C, Haouat N, et al. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma [ J ]. Ophthalmology, 1994, 101(3) :454 -460.
  • 2Pisella PJ, Debbasch C, Hamard P, et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study [ J ]. Invest Ophthalmol Vis Sci, 2004, 45 (5) : 1360 - 1368.
  • 3Berdy GJ, Abelson MB, Smith LM, et al. Preservative - free artificial tear preparations. Assessment of corneal epithelial toxic effects[J]. Arch Ophthalmol, 1992, 110 (4) : 528 -532.
  • 4Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications [ J ]. Cornea, 2004, 23 (5) : 490 - 496.
  • 5Lark KK, Pasha AS, Yan X, et al. The effect of latanoprost and brimonidine on rabbit subconjunctival fibroblasts [J]. J Glaucoma, 1999, 8(1) : 72 -76.
  • 6余敏斌,方敏,葛坚,黄圣松.1%派立明滴眼液联合0.25%贝特舒混悬液的临床降眼压疗效及安全性观察[J].眼科学报,2005,21(4):137-140. 被引量:4
  • 7石晶明,蒋幼芹,葛坚,刘磊,孙兴怀,陈晓明,余敏斌,孙丽,郭文毅,李茅.派立明与贝特舒联合用药对青光眼和高眼压症疗效的多中心研究[J].中国实用眼科杂志,2004,22(12):969-972. 被引量:6
  • 8Debbasch C, Brignole F, Pisella PJ, et al. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells [ J ]. Invest Ophthalmol Vis Sci, 2001,42(3) : 642 -652.
  • 9De Saint Jean M, Debbasch C, Brignole F, et al. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells [ J ]. Curr Eye Res, 2000, 20 (2) : 85 - 94.
  • 10Doughty MJ. Twice - daily use of a chlorobutanol -preserved artificial tear on rabbit corneal epithelium assessed by scanning electron microscopy [ J]. Ophthalmic Physiol Opt, 1992, 12(4):457-466.

二级参考文献16

  • 1[3]Cvetkovic RS,Perry CM.Brinzolamide:a review of its use in the management of primary open-angle glaucoma and ocular hypertension.Drugs Aging,2003;20(12):919-947.
  • 2[4]Shin D.Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with openangle glaucoma or ocular hypertension maintained on timolol therapy.Surv Ophthalmol,2000;44 Suppl 2:S163-168.
  • 3[5]Michaud JE,Friren B.International Brinzolamide Adjunctive Study Group.Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.Am J Ophthalmol,2001; 132(2):235-243.
  • 4[6]Silver LH.Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt).Brinzolamide Dose-Response Study Group.Surv Ophthalmol,2000; 44 Suppl 2:S147-153.
  • 5[7]Silver LH.Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution:results from two multicenter comfort studies.Brinzolamide Comfort Study Group.Surv Ophthalmol,2000; 44 Suppl 2:S141-145.
  • 6[8]Sall K.The efficacy and safety of brinzolamide 1%ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension.Brinzolamide Primary Therapy Study Group.Surv Ophthalmol,2000; 44 Suppl 2:S155-162.
  • 7[9]March WF,Ochsner KI.The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension.The Brinzolamide Long-Term Therapy Study Group.Am J Ophthalmol,2000; 129(2):136-143.
  • 8[10]Herkel U,Pfeiffer N.Update on topical carbonic anhydrase inhibitors.Curr Opin Ophthalmol,2001;12(2):88-93.
  • 9Herkel U, Pfeiffer N. Upda te on topical carbonic anhydrase inhibitors.Curr Opin Ophthalmol, 2001, 12 (2): 88~93. Review
  • 10Cvetkovic RS, Perry CM. Brinzolamide: a review of its use in the management of primary open - angle glaucoma and ocular hypertension. Drugs Aging, 2003, 20 (12): 919~947

共引文献8

同被引文献132

引证文献11

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部